Navigation Links
Cambrex To Present At Jefferies 2012 Global Healthcare Conference
Date:5/15/2012

EAST RUTHERFORD, N.J., May 15, 2012 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that Steve Klosk, President and Chief Executive Officer, will make a presentation on the Company at the Jefferies 2012 Global Healthcare Conference on June 4, 2012 at 9:30 AM EDT in New York City.

The audio webcast and slide presentation can be accessed for 30 days from the Jefferies website at http://www.wsw.com/webcast/jeff68/cbm or the Cambrex website for 90 days at http://www.cambrex.com in the Investors section of the website under Webcasts & Presentations. 

About Cambrex
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.  We offer Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Our development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products.  For more information, please visit www.cambrex.com.  


'/>"/>
SOURCE Cambrex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cambrex Reports First Quarter 2012 Results
2. Cambrex to Present at UBS 22nd Annual Global Healthcare Services Conference
3. Cambrex Reports Third Quarter 2011 Results
4. Cambrex to Announce Third Quarter 2011 Financial Results on November 3, 2011
5. Cambrex to Announce Second Quarter 2011 Financial Results on August 2, 2011
6. Cambrex Reports First Quarter of 2011 Results
7. Cambrex Reports Fourth Quarter and Full Year 2010 Results
8. Cambrex to Announce Fourth Quarter 2010 Financial Results on February 10, 2011
9. Cambrex Zenara Manufacturing Facility Receives European GMP Approval
10. Shawn P. Cavanagh Appointed Chief Operating Officer of Cambrex
11. Cambrex Zenara Supplies Product for Launch of Nicorette® in India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... April 28, 2016 New ... 2016" is a report that provides an overview ... R&D pipelines by identifying new targets and MOAs ... Company Profiles discussed in this H1 2016 Osteoarthritis ... Srl, AbbVie Inc., Abiogen Pharma S.p.A., Ablynx NV, ...
(Date:4/27/2016)... 2016 Im ... Zürich gab Strekin AG den Start einer ... Erhaltung des Resthörvermögens von Patienten, denen ein ... umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe werden momentan Patienten ... während der Operation direkt ins Mittelohr verabreicht. ...
(Date:4/27/2016)... , April 27, 2016 ... Including 42% Growth in Recurring Consumable Sales  ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor ... announced its sales for the first quarter ended March ... and the execution of its commercial strategy. ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... A new ... with severe congenital diaphragmatic hernia have better survival rates if surgery is performed ... (CDH)—a condition where the diaphragm fails to form completely, letting abdominal organs into ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... won the $30,000 Perlman Grand Prize of the 2016 Wharton Business Plan ... the Michelson People’s Choice Award, and the Committee Award for Most ‘Wow Factor,’ ...
(Date:4/29/2016)... NY (PRWEB) , ... April 29, 2016 , ... ... and engineer of patented products, announces the Gyrociser, an exercise invention which aids ... worth $2 billion," says Scott Cooper, CEO and Creative Director of World Patent ...
(Date:4/29/2016)... ... April 29, 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about ... of skin cancer deaths. More than 10,000 people are expected to die of melanoma this ... it is the one of the most commonly diagnosed cancers in young women. A recent ...
(Date:4/29/2016)... ... , ... New York City based oral and maxillofacial surgeon Dr. Majid Jamali is ... treat obstructive sleep apnea. Dr. Jamali is proud to offer this permanent solution to patients ... or both jaw bones. This surgery is performed to correct the alignment of the jaw. ...
Breaking Medicine News(10 mins):